As per MRFR analysis, the US Single-Use Bioprocessing Market Size was estimated at 3.47 (USD Billion) in 2023. The US Single-Use Bioprocessing Market Industry is expected to grow from 4.19 (USD Billion) in 2024 to 9.1 (USD Billion) by 2035. The US Single-Use Bioprocessing Market CAGR (growth rate) is expected to be around 7.294% during the forecast period (2025 - 2035).
The US Single-Use Bioprocessing Market is significantly influenced by several key market drivers. The increasing demand for biopharmaceuticals has fueled the need for efficient production methods, making single-use technologies attractive due to their flexibility and reduced operational costs. The US government has been supportive of bioprocess innovation, promoting initiatives that encourage the adoption of advanced manufacturing technologies. This has led to a surge in investments and research dedicated to enhancing single-use systems and addressing regulatory requirements.
Moreover, the ongoing shift towards personalized medicine in the US further drives the demand for single-use bioprocessing, as these systems are more adaptable to smaller-scale production runs.In recent times, there are numerous opportunities to be explored within the US Single-Use Bioprocessing Market. Companies are focusing on integrating digital technologies and automation to further optimize single-use processes. The growing interest in cell and gene therapies in the US presents a lucrative opportunity, as single-use systems can provide the desired flexibility for the production of these complex therapies.
The emergence of collaboration between biopharma companies and technology providers can also result in innovative solutions that enhance efficiency and safety in production. Trends in the US market reflect an increasing emphasis on sustainability and reducing environmental impact.Manufacturers are actively seeking eco-friendly materials for single-use products, aligning with the broader environmental goals set forth by federal and state regulations. Additionally, there is a rising trend towards the use of modular and hybrid systems, which allow for greater scalability. This evolution in the market indicates a move towards a more integrated and user-centered approach in bioprocessing, ensuring that the US maintains its leadership in biopharmaceutical production innovation.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US is experiencing a significant growth in the biopharmaceutical sector, driven by an increase in chronic diseases and aging population. According to the Centers for Disease Control and Prevention (CDC), around 60% of adults in the US have a chronic disease, and 40% have two or more. This rising prevalence is prompting pharmaceutical companies to invest more in the development of biopharmaceutical products. Companies like Amgen and Genentech are expanding their production capabilities with single-use bioprocessing technologies to meet this demand.
The flexibility and efficiency provided by single-use systems enable faster turnaround times for biopharmaceutical production, catering to an ever-increasing patient population that requires specialized treatments. The US Single-Use Bioprocessing Market Industry is thus poised for accelerated growth, as established organizations leverage these technologies to improve their production pipelines.
The integration of advanced technologies in bioprocessing is a major driver for the US Single-Use Bioprocessing Market. The introduction of automation and digitalization in processes has made biomanufacturing more efficient and reliable. For instance, the US Food and Drug Administration (FDA) has reported that more than 70% of biotechnology firms are adopting single-use systems due to their ease of use and reduced cross-contamination risks. Major players like Thermo Fisher Scientific and Sartorius are leading the charge in developing innovative single-use products that enhance productivity and ensure compliance with stringent regulatory standards.
The focus on innovation, supported by substantial Research and Development investments, is critical to the growth of the US Single-Use Bioprocessing Market Industry.
In the US, the bioprocessing industry is increasingly turning towards cost-effective solutions to maintain profitability. Single-use bioprocessing systems significantly reduce capital investment and operational costs associated with cleaning and sterilization of conventional systems. According to the BioProcess International magazine, switching to single-use technology can lower costs by up to 30% per unit operation, which is especially crucial for small to medium-sized enterprises.
Companies such as Merck and Pfizer actively implement single-use manufacturing strategies to optimize their operations, reflecting a broader market trend towards efficiency and sustainability. The cost advantages of single-use systems are a key growth factor driving the US Single-Use Bioprocessing Market Industry.
The US Single-Use Bioprocessing Market reflects a significant shift towards more efficient, flexible, and cost-effective biomanufacturing solutions. With innovations driving the development of single-use technologies, the market features various key products that serve essential roles in bioprocessing applications. Filtration Assemblies play a crucial role in maintaining product integrity and ensuring sterility during bioprocessing, significantly impacting yield and quality.
Disposable Bioreactors represent a prominent trend in the industry, as they facilitate bioproduction without the need for extensive cleaning and validation, thereby enhancing operational efficiency.Alongside these, Disposable Mixers are gaining traction due to their ability to ensure homogeneity in fluid mixing processes, a critical aspect in upstream and downstream processing. Media Bags and Containers serve as vital components for storing and transporting cell culture media and other solutions, underscoring the demand for containers that minimize contamination risks while ensuring easy accessibility.
The diverse applications of these products showcase their importance in the bioprocessing landscape, often catering to the growing needs of the pharmaceutical and biotechnology sectors.As the US Single-Use Bioprocessing Market continues to expand, these products are expected to adapt to meet stringent regulatory requirements and achieve operational excellence, thereby capturing a critical portion of the market share in years to come. Overall, the segmentation of products plays a pivotal role in supporting the flexibility and scalability that modern bioprocessing requires, ultimately driving innovation and growth within the industry.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Application segment of the US Single-Use Bioprocessing Market plays a pivotal role in addressing the growing demands of the biopharmaceutical industry. This segment encompasses various functionalities including Filtration, Purification, Cell Culture, and others, each contributing uniquely to the bioprocessing landscape. Filtration processes significantly enhance product safety and quality in the manufacturing of biopharmaceuticals, while Purification techniques are crucial for isolating and refining biologics, thus ensuring the efficacy of therapeutic agents.
Cell Culture applications are vital as they support the production of vaccines and monoclonal antibodies, reflecting a robust demand triggered by advancements in personalized medicine and biologic therapies. Additionally, other applications continue to innovate, catering to specific customer requirements, driven by technological advancements and regulatory changes. The increasing adoption of single-use technologies, coupled with the need for cost-effective and efficient biomanufacturing solutions, underscores the growth potential within the US Single-Use Bioprocessing Market.
Overall, the dynamics within this segment highlight a progressive trend towards scalable and adaptable bioprocessing methodologies, aligning with the industry's direction towards sustainability and enhanced productivity.
The End-User segment of the US Single-Use Bioprocessing Market plays a crucial role in driving the industry forward, with Biopharmaceutical Manufacturers being a dominant force due to their extensive reliance on efficient and cost-effective bioprocessing solutions. These manufacturers increasingly adopt single-use technologies to streamline production processes, minimize contamination risks, and reduce overall operational costs. Clinical and Academic Research Institutes also significantly contribute to market dynamics, utilizing innovative bioprocessing techniques as they pursue groundbreaking research and drug development initiatives.
The demand for flexibility and scalability in manufacturing processes leads to an emphasis on single-use systems, allowing these institutions to operate with enhanced efficiency and reduced turnaround times. Additionally, a range of other users, spanning various sectors, further enriches the market landscape by diversifying applications and fostering innovation within the industry. This increased variety enhances the overall adaptability and responsiveness of the US Single-Use Bioprocessing Market as it evolves to meet the specific needs of different End-User groups.
As these users continue to prioritize advancements in bioprocessing, the market is expected to witness sustained growth, reflecting a broader trend toward modernization and technological adoption across the biopharmaceutical space.
The US Single-Use Bioprocessing Market, particularly the Workflow segment, is experiencing noteworthy growth driven by various technological advancements and increasing demand for biologics. The Workflow segment encompasses essential processes such as Upstream, Fermentation, and Downstream, each playing a vital role in bioprocessing efficiency. Upstream processes focus on cell culture and the initial stages of production, ensuring high cellular yield, which is critical for the efficacy of biologics. Fermentation, a crucial element, transforms substrates into desired products, highlighting its importance in meeting the rising demand for therapeutics.
Downstream processes emphasize the purification and formulation of products, ensuring quality and compliance with regulatory standards, which is significant in the highly regulated US market. The trend toward automation and integration within the Workflow segment is enhancing productivity and reducing operational costs. There's also a growing emphasis on sustainability and cost-efficiency, which drives the adoption of single-use technologies. As biopharmaceutical companies continuously seek innovative solutions to enhance their production capabilities, the Workflow segment stands out as a cornerstone of operational excellence within the US Single-Use Bioprocessing Market, offering substantial opportunities for growth and development.
The US Single-Use Bioprocessing Market is characterized by dynamic competition among key players focusing on the development and advancement of bioprocessing technologies tailored for the biopharmaceutical industry. The competitive landscape features a mix of established global corporations and emerging companies that aim to enhance operational efficiency, reduce contamination risks, and provide flexible solutions for pharmaceutical manufacturing. This market has seen significant growth due to an increased demand for biologics, advanced therapies, and streamlined production processes.
As a result, companies are investing in innovation, forming strategic partnerships, and expanding their product portfolios to gain a competitive edge in this rapidly evolving environment. Market leaders are continuously seeking ways to enhance their offerings and drive operational excellence, which is shaping the future of bioprocessing technology in the United States.
Danaher Corporation holds a significant position in the US Single-Use Bioprocessing Market, where it leverages its diverse portfolio of technologies to provide robust bioprocessing solutions. The company's strengths lie in its commitment to innovation, quality assurance, and customer support, allowing it to meet the stringent demands of the biopharmaceutical sector. Danaher’s extensive range of single-use products is designed to enhance efficiency and minimize the risks associated with traditional bioprocessing methods. The company's clear focus on R&D continues to yield advanced solutions that are central to the production of monoclonal antibodies and other biologics.
Danaher Corporation also enjoys a strong market presence owing to its reputation for reliability and excellence, facilitating partnerships with key industry stakeholders and fostering a collaborative approach to bioprocessing challenges.
Lonza Group is another prominent player in the US Single-Use Bioprocessing Market, with a well-established reputation for its high-quality contract manufacturing services and product offerings. The company provides a comprehensive range of single-use bioprocessing solutions, including bioreactors, cell culture bags, and filtration devices. Lonza's strengths lie in its extensive experience, innovative product line, and commitment to enhancing bioprocessing efficiency for its clients. The company has engaged in significant mergers and acquisitions to expand its capabilities and strengthen its position in the market.
Through these strategic movements, Lonza has broadened its service offering, making it a preferred choice for companies seeking reliable biopharmaceutical manufacturing solutions. By integrating advanced technologies and maintaining high-quality standards, Lonza Group effectively addresses the evolving needs of the bioprocessing landscape in the United States, thereby maintaining a forward-thinking approach in this competitive sector.
In the US Single-Use Bioprocessing Market, recent developments have showcased significant growth and investment activities. Leading companies like Danaher Corporation and Thermo Fisher Scientific have expanded their product portfolios and enhanced their manufacturing capabilities to meet the growing demand for single-use technologies in bioprocessing. Particularly in August 2023, AbbVie announced the establishment of a new facility focusing on single-use systems, signaling a strong commitment to advancing bioprocessing technologies.
Additionally, Merck KGaA has invested heavily in research to optimize the use of single-use bioreactors, reinforcing its position in the market. Notable merger activities include Baxter International's acquisition of a bioprocessing company in July 2023, aimed at consolidating its presence in the single-use segment. The market valuation for companies like Repligen Corporation has seen a significant increase due to heightened demand as regulators emphasize more flexible and efficient manufacturing methods. Eppendorf AG reported substantial revenue growth in recent quarters, reflecting the robust market dynamics. The push towards sustainable practices, such as recycling single-use components, is also shaping industry trends as companies look to meet regulatory and environmental standards.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 3.47(USD Billion) |
| MARKET SIZE 2024 | 4.19(USD Billion) |
| MARKET SIZE 2035 | 9.1(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.294% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Danaher Corporation, Lonza Group, GE Healthcare, Abcam plc, Baxter International, Thermo Fisher Scientific, Fujifilm Diosynth Biotechnologies, Repligen Corporation, Waters Corporation, Sartorius AG, 3M Company, Pall Corporation, Celtic Therapeutics, Merck KGaA, Eppendorf AG |
| SEGMENTS COVERED | Product, Application, End-User, Workflow |
| KEY MARKET OPPORTUNITIES | Increased demand for biopharmaceuticals, Rising investments in biotechnology, Advancements in single-use technologies, Growing focus on cost efficiency, Expansion of contract manufacturing organizations |
| KEY MARKET DYNAMICS | growing demand for biologics, cost efficiency and flexibility, innovation in manufacturing technologies, regulatory compliance requirements, increased adoption of personalized medicine |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Single-Use Bioprocessing Market is expected to be valued at approximately 4.19 billion USD in 2024.
By 2035, the US Single-Use Bioprocessing Market is projected to reach around 9.1 billion USD.
The expected CAGR for the US Single-Use Bioprocessing Market from 2025 to 2035 is approximately 7.294 percent.
By 2035, the Filtration Assemblies product segment is expected to dominate with a projected value of 2.39 billion USD.
The market size for Disposable Bioreactors in 2024 is valued at around 1.25 billion USD.
By 2035, the Disposable Mixers segment is projected to achieve a value of approximately 1.6 billion USD.
Key players in the market include Danaher Corporation, Lonza Group, GE Healthcare, and Thermo Fisher Scientific among others.
The Media Bags and Containers segment is expected to be valued at around 0.85 billion USD in 2024.
Growth drivers include increasing demand for biopharmaceuticals and the rising trend towards cost-effective bioproduction.
Challenges include potential regulatory hurdles and contamination risks associated with single-use systems.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
